Table 3.
Braun et al., 2012 | Braun et al., 2009 | Sherif et al., 2008 | Garosi et al., 2005 | Honda et al., 2003 | |
EPS patients (n) | 31 | 9 | 12 | 39 | 12 |
Non-EPS PD patients (n) | 27 | 10 | 30 | 180 | 57 |
Visceral (V) or parietal (P) | – | V | – | V and P | – |
Histologic parameters | Significance between EPS and non-EPS PD patients | ||||
Fibrosis | S | S | S | – | NS |
Degenerated layer thickness | – | – | S | – | – |
Fibroblast like cells | S | – | – | – | – |
Inflammation | NS | – | – | S | S |
Mesothelial denudation | S | – | NS | – | NS |
Vasculopathy | NS | S | – | S | NS |
Fibrin deposition | S | – | S | – | S |
Vessel density | NS | S | – | – | – |
Fe deposits | S | – | – | – | – |
Decreased cellularity | S | – | – | – | – |
Fibroblast enlargement | – | – | – | – | S |
Capillary angiogenesis | – | – | – | – | S |
Calcification | NS | – | – | S | – |
(S) and (NS) denote significance and non-significance, respectively. (–) denotes data not being measured or recorded.